ESC Premium Access

Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

Congress Presentation

About the speaker

Doctor Praveen Chandra

Gurgaon (India)
0 follower

9 more presentations in this session

Early and Late target lesion failure and thrombosis after implantation of coronary bioresorbable scaffolds: analysis of predictors and mechanisms.

Speaker: Doctor T. Gori (Mainz, DE)


Major coronary evaginations following implantation of bioresorbable vascular scaffolds: clinical and OCT characteristics

Speaker: Doctor F. Blachutzik (Giessen, DE)


One-year clinical outcomes following bioresorbable vascular scaffold implantation in patients presenting with acute coronary syndromes versus stable coronary artery disease: results from RAI registry

Speaker: Doctor E. Moscarella (Caserta, IT)


Bioresorbable vascular scaffolds versus metallic stents in patients with STsegment

Speaker: Doctor T. Kofler (Altdorf, CH)


Computed Tomography Coronary Angiography Long-term Results of Bioresorbable Vascular Scaffold in clinical practice. A BVS-Expand project

Speaker: Professor R. van Geuns (Nijmegen, NL)


Access the full session

Bioresorbable vascular scaffolds: still the future or already the past?

Speakers: Doctor P. Chandra, Doctor T. Gori, Doctor F. Blachutzik, Doctor E. Moscarella, Doctor T. Kofler...

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb